Cargando…

Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma

Background. Advanced basal cell carcinoma (BCC) is often treated by surgery or X-ray therapy. The consequences of X-ray therapy on the patients' health-related quality-of-life (HRQOL) have so far not been described. Objectives. To quantify quality of life in BCC patients before and after X-ray...

Descripción completa

Detalles Bibliográficos
Autores principales: Skiveren, Jette, Mikkelsen, Maria Rudkjaer, Daugbjerg, Helle, Wulf, Hans Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539380/
https://www.ncbi.nlm.nih.gov/pubmed/23316369
http://dx.doi.org/10.1155/2012/825095
_version_ 1782255076168957952
author Skiveren, Jette
Mikkelsen, Maria Rudkjaer
Daugbjerg, Helle
Wulf, Hans Christian
author_facet Skiveren, Jette
Mikkelsen, Maria Rudkjaer
Daugbjerg, Helle
Wulf, Hans Christian
author_sort Skiveren, Jette
collection PubMed
description Background. Advanced basal cell carcinoma (BCC) is often treated by surgery or X-ray therapy. The consequences of X-ray therapy on the patients' health-related quality-of-life (HRQOL) have so far not been described. Objectives. To quantify quality of life in BCC patients before and after X-ray therapy compared with matched healthy controls. Materials. Twenty-five patients (mean age 69) with BCC completed the Dermatology Life Quality Index (DLQI) before and two weeks and three months after X-ray therapy and their results were compared with the DLQI scores for 25 matched controls. Results. Compared to the healthy controls the patients' DLQI score was significantly higher before and 2 weeks after X-ray therapy (P = 0.005; P = 0.000). The patients' DLQI score decreased significantly from baseline to three months after X-ray therapy (P = 0.024), when it became similar to that of the healthy controls (P = 0.819). Three months after X-ray therapy eight patients had no skin reactions, 11 had slight atrophy, pigmentation change, and/or some hair loss, four had patch atrophy, moderate telangiectasia, and/or total hair loss. Conclusions. BCC has a negative effect on patients' quality of life. The study shows that HRQOL normalises shortly after X-ray therapy, despite minor skin manifestations.
format Online
Article
Text
id pubmed-3539380
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-35393802013-01-11 Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma Skiveren, Jette Mikkelsen, Maria Rudkjaer Daugbjerg, Helle Wulf, Hans Christian J Skin Cancer Clinical Study Background. Advanced basal cell carcinoma (BCC) is often treated by surgery or X-ray therapy. The consequences of X-ray therapy on the patients' health-related quality-of-life (HRQOL) have so far not been described. Objectives. To quantify quality of life in BCC patients before and after X-ray therapy compared with matched healthy controls. Materials. Twenty-five patients (mean age 69) with BCC completed the Dermatology Life Quality Index (DLQI) before and two weeks and three months after X-ray therapy and their results were compared with the DLQI scores for 25 matched controls. Results. Compared to the healthy controls the patients' DLQI score was significantly higher before and 2 weeks after X-ray therapy (P = 0.005; P = 0.000). The patients' DLQI score decreased significantly from baseline to three months after X-ray therapy (P = 0.024), when it became similar to that of the healthy controls (P = 0.819). Three months after X-ray therapy eight patients had no skin reactions, 11 had slight atrophy, pigmentation change, and/or some hair loss, four had patch atrophy, moderate telangiectasia, and/or total hair loss. Conclusions. BCC has a negative effect on patients' quality of life. The study shows that HRQOL normalises shortly after X-ray therapy, despite minor skin manifestations. Hindawi Publishing Corporation 2012 2012-12-20 /pmc/articles/PMC3539380/ /pubmed/23316369 http://dx.doi.org/10.1155/2012/825095 Text en Copyright © 2012 Jette Skiveren et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Skiveren, Jette
Mikkelsen, Maria Rudkjaer
Daugbjerg, Helle
Wulf, Hans Christian
Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma
title Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma
title_full Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma
title_fullStr Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma
title_full_unstemmed Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma
title_short Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma
title_sort skin reactions and quality of life after x-ray therapy of basal cell carcinoma
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539380/
https://www.ncbi.nlm.nih.gov/pubmed/23316369
http://dx.doi.org/10.1155/2012/825095
work_keys_str_mv AT skiverenjette skinreactionsandqualityoflifeafterxraytherapyofbasalcellcarcinoma
AT mikkelsenmariarudkjaer skinreactionsandqualityoflifeafterxraytherapyofbasalcellcarcinoma
AT daugbjerghelle skinreactionsandqualityoflifeafterxraytherapyofbasalcellcarcinoma
AT wulfhanschristian skinreactionsandqualityoflifeafterxraytherapyofbasalcellcarcinoma